LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report.

    Shimamoto, Yuki / Sasaki, Hirohito / Kasuno, Kenji / Watanabe, Yuki / Sakashita, Sayumi / Nishikawa, Sho / Nishimori, Kazuhisa / Morita, Sayu / Nishikawa, Yudai / Kobayashi, Mamiko / Fukushima, Sachiko / Enomoto, Soichi / Takahashi, Naoki / Hamano, Tadanori / Sakamaki, Ippei / Iwasaki, Hiromichi / Iwano, Masayuki

    BMC nephrology

    2023  Volume 24, Issue 1, Page(s) 286

    Abstract: ... discharged without sequelae.: Conclusions: We report the first case of PRES associated with SARS-CoV-2 ... previous report has yet described PRES associated with SARS-CoV-2 infection among patients undergoing ... SARS-CoV-2 infection possibly be associated with the development of PRES. ...

    Abstract Background: Endothelial dysfunction is common in patients undergoing chronic haemodialysis, and is a major cause of posterior reversible encephalopathy syndrome (PRES). Recently, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to cause endothelial dysfunction by infecting vascular endothelial cells. Several cases of neurological complications in patients without kidney dysfunction, and only a few cases in patients with chronic kidney disease, have been reported in the literature. However, no previous report has yet described PRES associated with SARS-CoV-2 infection among patients undergoing maintenance dialysis.
    Case presentation: A 54-year-old woman undergoing maintenance haemodialysis was admitted to our hospital for status epilepticus. She had developed end-stage kidney disease (ESKD) secondary to diabetic nephropathy. Seven days prior to admission, she had developed fever and was diagnosed with COVID-19. Subsequently her blood pressure increased from 160/90 mmHg to 190/100 mmHg. On admission, she presented with severe hypertension (> 220/150 mmHg), unconsciousness, and epilepticus. CT tomography revealed no signs of brain haemorrhage. Cranio-spinal fluid (CSF) examination revealed no signs of encephalitis, and CSF polymerase chain reaction (PCR) for SARS-CoV-2 was negative. MRI findings revealed focal T2/FLAIR hyperintensity in the bilateral parietooccipital regions, leading to the diagnosis of PRES. Deep sedation and strict blood pressure control resulted in a rapid improvement of her symptoms, and she was discharged without sequelae.
    Conclusions: We report the first case of PRES associated with SARS-CoV-2 infection in a patient undergoing maintenance haemodialysis. Patients undergoing maintenance haemodialysis are at high risk of PRES because of several risk factors. SARS-CoV-2 infection causes direct invasion of endothelial cells by binding to angiotensin-converting enzyme 2 (ACE2), initiating cytokine release, and hypercoagulation, leading to vascular endothelial cell injury and increased vascular leakage. In the present case, SARS-CoV-2 infection possibly be associated with the development of PRES.
    MeSH term(s) Humans ; Female ; Middle Aged ; Posterior Leukoencephalopathy Syndrome/etiology ; Posterior Leukoencephalopathy Syndrome/complications ; COVID-19/complications ; Endothelial Cells ; SARS-CoV-2 ; Renal Dialysis/adverse effects ; Vascular Diseases/complications
    Language English
    Publishing date 2023-09-29
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041348-8
    ISSN 1471-2369 ; 1471-2369
    ISSN (online) 1471-2369
    ISSN 1471-2369
    DOI 10.1186/s12882-023-03319-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review.

    Wang, Lishen / Wang, Zhihan / Huang, Rui / Li, Weishuai / Zheng, Dongming

    Medicine

    2024  Volume 103, Issue 5, Page(s) e37192

    Abstract: ... encephalopathy syndrome (PRES). In previously reported cases of PRES associated with COVID-19, the majority ... the infection of SARS-CoV-2 may play a direct role in the pathogenesis of PRES associated with COVID-19. ... of PRES in these patients. Here we report a special case of PRES associated with COVID-19 ...

    Abstract Rationale: During the past 3 years of the corona virus disease 2019 (COVID-19) pandemic, COVID-19 has been recognized to cause various neurological complications, including rare posterior reversible encephalopathy syndrome (PRES). In previously reported cases of PRES associated with COVID-19, the majority of patients had severe COVID-19 infection and known predisposing factors for PRES, such as uncontrolled hypertension, renal dysfunction, and use of immunosuppressants. It remains unclear whether these risk factors or infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributes to the development of PRES in these patients. Here we report a special case of PRES associated with COVID-19 without any known risk factors for PRES, indicating the SARS-CoV-2's direct role in the pathogenesis of PRES associated with COVID-19.
    Patient concerns: An 18-year-old female patient presented to the emergency department with abdominal pain. Preliminary investigations showed no abnormalities, except for positive results in novel coronavirus nucleic acid tests using oropharyngeal swabs. However, the patient subsequently developed tonic-clonic seizures, headaches, and vomiting on the second day. Extensive investigations have been performed, including brain MRI and lumbar puncture. Brain MRI showed hypointense T1-weighted and hyperintense T2-weighted lesions in the bilateral occipital, frontal, and parietal cortices without enhancement effect. Blood and cerebrospinal fluid analyses yielded negative results. The patient had no hypertension, renal insufficiency, autoimmune disease, or the use of immunosuppressants or cytotoxic drugs.
    Diagnoses: PRES was diagnosed based on the clinical features and typical MRI findings of PRES.
    Interventions: Symptomatic treatments such as anticonvulsants were administered to the patients.
    Outcomes: The patient fully recovered within 1 week. The initial MRI abnormalities also disappeared completely on a second MR examination performed 11 days later, supporting the diagnosis of PRES. The patient was followed up for 6 months and remained in a normal state.
    Lessons: The current case had no classical risk factors for PRES, indicating that although the cause of PRES in COVID-19 patients may be multifactorial, the infection of SARS-CoV-2 may play a direct role in the pathogenesis of PRES associated with COVID-19.
    MeSH term(s) Female ; Humans ; Adolescent ; Posterior Leukoencephalopathy Syndrome/complications ; SARS-CoV-2 ; COVID-19/complications ; Seizures/complications ; Hypertension/complications ; Immunosuppressive Agents/therapeutic use
    Chemical Substances Immunosuppressive Agents
    Language English
    Publishing date 2024-02-02
    Publishing country United States
    Document type Review ; Case Reports ; Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000037192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report

    Ordoñez-Boschetti, L. / Torres-Romero, C.M. / Ortiz De Leo, M.J.

    Neurología (English Edition) ; ISSN 2173-5808

    2020  

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.nrleng.2020.08.006
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article: Síndrome de encefalopatía posterior reversible (PRES) asociado a SARS-CoV-2. Reporte de caso./ Síndrome de encefalopatía posterior reversible (PRES) asociado a SARS-CoV-2. Reporte de caso./ Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report

    Ordoñez-Boschetti, L / Torres-Romero, C M / Ortiz de Leo, M J

    Neurologia (Barc., Ed. impr.)

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #704012
    Database COVID19

    Kategorien

  5. Article: SARS-CoV-2 associated posterior reversible encephalopathy syndrome (PRES) - a review of 82 cases.

    Finsterer, J

    The Medical journal of Malaysia

    2023  Volume 78, Issue 3, Page(s) 421–426

    Abstract: ... summarises and discusses previous and recent findings on SARS-CoV-2 associated PRES.: Methods ... patients with SARS-CoV-2 associated PRES were recorded. The latency between the onset of COVID-19 and ... Disease-19 (COVID- 19) is posterior reversible encephalopathy syndrome (PRES). This narrative review ...

    Abstract Objectives: Severe, acute, respiratory syndromecoronavirus- 2 (SARS-CoV-2) infections can be complicated by central nervous system (CNS) disease. One of the CNS disorders associated with Coronavirus Disease-19 (COVID- 19) is posterior reversible encephalopathy syndrome (PRES). This narrative review summarises and discusses previous and recent findings on SARS-CoV-2 associated PRES.
    Methods: A literature search was carried out in PubMed and Google Scholar using suitable search terms and reference lists of articles found were searched for further articles.
    Results: By the end of February 2023, 82 patients with SARS-CoV-2 associated PRES were recorded. The latency between the onset of COVID-19 and the onset of PRES ranged from 1 day to 70 days. The most common presentations of PRES were mental deterioration (n=47), seizures (n=46) and visual disturbances (n=18). Elevated blood pressure was reported on admission or during hospitalisation in 48 patients. The most common comorbidities were arterial hypertension, diabetes, hyperlipidemia and atherosclerosis. PRES was best diagnosed by multimodal cerebral magnetic resonance imaging (MRI). Complete recovery was reported in 35 patients and partial recovery in 21 patients, while seven patients died.
    Conclusions: PRES can be a CNS complication associated with COVID-19. COVID-19 patients with mental dysfunction, seizures or visual disturbances should immediately undergo CNS imaging through multimodal MRI, electroencephalography (EEG) and cerebrospinal fluid (CSF) studies in order not to miss PRES.
    MeSH term(s) Humans ; Posterior Leukoencephalopathy Syndrome/diagnosis ; Posterior Leukoencephalopathy Syndrome/etiology ; SARS-CoV-2 ; COVID-19/complications ; Seizures/etiology ; Electroencephalography/adverse effects ; Electroencephalography/methods ; Hypertension/complications ; Magnetic Resonance Imaging/methods
    Language English
    Publishing date 2023-06-05
    Publishing country Malaysia
    Document type Review ; Journal Article
    ZDB-ID 604286-7
    ISSN 0300-5283
    ISSN 0300-5283
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Case report: Thrombotic microangiopathy in pediatric multisystem inflammatory syndrome associated with COVID-19: a case series.

    Nalçacıoğlu, Hülya / Önal, H Gözde / Bozkaya Yücel, Burcu / Tekcan Karali, Demet / Erdeniz, Emine / Öz Tuncer, Gökçen / Aydoğ, Özlem

    Frontiers in pediatrics

    2023  Volume 11, Page(s) 1254308

    Abstract: ... hemolytic uremic syndrome (HUS), and posterior reversible encephalopathy syndrome (PRES) post-exposure to COVID-19 ... negative SARS-CoV-2 RT-PCR results, her condition escalated rapidly, presenting increased levels of LDH ... regimen.: Conclusion: This case series underscores that MIS-C-associated TMA is a significant ...

    Abstract Introduction: This report provides insight into three distinct pediatric cases exhibiting a nexus between multisystem inflammatory syndrome in children (MIS-C) and thrombotic microangiopathy (TMA) triggered by COVID-19. The aim is to underscore the range of clinical presentations and the essentiality of early interventions.
    Case presentations: This report presents three cases aged 10 months, 7 years, and 3 years with persistent fever, diarrhea, nausea, and vomiting. The first case, a 10-month-old girl, demonstrated acute kidney injury (AKI) and microangiopathic hemolytic anemia (MAHA) following a COVID-19 infection. Despite initial negative SARS-CoV-2 RT-PCR results, her condition escalated rapidly, presenting increased levels of LDH (peaking at 4,200 U/L) and requiring renal replacement therapy (RRT) to manage deteriorating renal function. Interventions with eculizumab and anakinra led to marked improvements, with a stable follow-up of 13 months post-hospitalization. The second case involved a 7-year-old girl who developed symptoms of MIS-C, hemolytic uremic syndrome (HUS), and posterior reversible encephalopathy syndrome (PRES) post-exposure to COVID-19, evidenced by heightened LDH levels (3,522 U/L at peak). After a precarious period of deteriorating kidney function and exacerbated hypertension, she responded positively to treatments, inclusive of IVIG, steroid therapies, and eculizumab, with a favorable 6-month follow-up showcasing stable laboratory results. The third case discusses a 3-year-old boy, without any medical history, manifesting HUS symptoms and COVID-19 infection. He exhibited increased LDH levels (peaking at 3,946 U/L) alongside elevated creatinine, marking renal impairment. He responded well to hemodialysis, IVIG, and steroid therapy, showcasing substantial recovery by the 19th day of hospitalization, which marked his discharge with a tapering steroid regimen.
    Conclusion: This case series underscores that MIS-C-associated TMA is a significant complication in pediatric COVID-19. Our findings illuminate the potential for treatment success but simultaneously emphasize the need for a more comprehensive understanding of the underlying pathophysiology.
    Language English
    Publishing date 2023-10-12
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2023.1254308
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Neurological emergencies associated with COVID-19: stroke and beyond.

    Agarwal, Amit / Pinho, Marco / Raj, Karuna / Yu, Frank F / Bathla, Girish / Achilleos, Michael / ONeill, Thomas / Still, Michael / Maldjian, Joseph

    Emergency radiology

    2020  Volume 27, Issue 6, Page(s) 747–754

    Abstract: ... with subarachnoid hemorrhage, and posterior reversible encephalopathy syndrome (PRES). ... from ischemic stroke to acute demyelination and encephalitis. We report five cases of COVID-19 presenting ... Neurological manifestations are now being reported worldwide, including emergent presentation with acute neurological changes ...

    Abstract Novel coronavirus disease (COVID-19) was declared a global pandemic on March 1, 2020. Neurological manifestations are now being reported worldwide, including emergent presentation with acute neurological changes as well as a comorbidity in hospitalized patients. There is limited knowledge on the neurologic manifestations of COVID-19 at present, with a wide array of neurological complications reported, ranging from ischemic stroke to acute demyelination and encephalitis. We report five cases of COVID-19 presenting to the ER with acute neurological symptoms, over the course of 1 month. This includes two cases of ischemic stroke, one with large-vessel occlusion and one with embolic infarcts. The remainders of the cases include acute tumefactive demyelination, isolated cytotoxic edema of the corpus callosum with subarachnoid hemorrhage, and posterior reversible encephalopathy syndrome (PRES).
    MeSH term(s) Adult ; Aged ; Betacoronavirus ; Brain Diseases/diagnostic imaging ; Brain Diseases/therapy ; Brain Diseases/virology ; COVID-19 ; Cerebral Angiography ; Computed Tomography Angiography ; Coronavirus Infections/complications ; Coronavirus Infections/therapy ; Emergencies ; Fatal Outcome ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Neuroimaging/methods ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/therapy ; Posterior Leukoencephalopathy Syndrome/diagnostic imaging ; Posterior Leukoencephalopathy Syndrome/therapy ; Posterior Leukoencephalopathy Syndrome/virology ; SARS-CoV-2 ; Stroke/diagnostic imaging ; Stroke/therapy ; Stroke/virology
    Keywords covid19
    Language English
    Publishing date 2020-08-11
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1425144-9
    ISSN 1438-1435 ; 1070-3004
    ISSN (online) 1438-1435
    ISSN 1070-3004
    DOI 10.1007/s10140-020-01837-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Foreign accent syndrome and other neuropsychological sequelae of a parieto-occipital lesion following COVID-19 associated posterior reversible encephalopathy syndrome.

    Hill, Geoff / Archibald, Neil / Larkin, Poppy / Farquhar, Jenny / Evans, Jonathan

    The Clinical neuropsychologist

    2022  Volume 37, Issue 6, Page(s) 1321–1335

    Abstract: ... and persisting neuropsychological impairments following a posterior reversible encephalopathy syndrome ... to the neuropsychological literature on PRES, FAS and acquired brain injury as a rare complication of SARS-CoV-2. ... from other aetiologies, COVID-19 associated PRES can in some cases cause irreversible acquired brain injury. The diverse ...

    Abstract Objective: We describe a previously fit and well 54-year-old female who acquired a range of severe and persisting neuropsychological impairments following a posterior reversible encephalopathy syndrome (PRES) complication of COVID-19. The initial presentation included aphasia, a neurogenic foreign accent syndrome (FAS) and a persisting complete cortical blindness from the underpinning parieto-occipital brain injury.
    Method: Neuropsychological single clinical case report.
    Results: The patient retained insight and made good early progress with their adjustment to the numerous losses caused by the COVID-19 associated acquired brain injury. Comprehensive neuropsychological investigation characterised an acalculia, along with deficits in focused, sustained and divided attention impacting on verbal memory, working memory and executive functioning, amongst numerous relative strengths.
    Conclusion: Similar to PRES from other aetiologies, COVID-19 associated PRES can in some cases cause irreversible acquired brain injury. The diverse neuropsychological effects need to be comprehensively investigated and managed. This case adds to the neuropsychological literature on PRES, FAS and acquired brain injury as a rare complication of SARS-CoV-2.
    MeSH term(s) Female ; Humans ; Middle Aged ; Posterior Leukoencephalopathy Syndrome/complications ; Posterior Leukoencephalopathy Syndrome/diagnostic imaging ; Magnetic Resonance Imaging ; COVID-19/complications ; SARS-CoV-2 ; Neuropsychological Tests ; Brain Injuries/complications
    Language English
    Publishing date 2022-08-24
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 639080-8
    ISSN 1744-4144 ; 0920-1637 ; 1385-4046
    ISSN (online) 1744-4144
    ISSN 0920-1637 ; 1385-4046
    DOI 10.1080/13854046.2022.2108903
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).

    Harapan, Biyan Nathanael / Yoo, Hyeon Joo

    Journal of neurology

    2021  Volume 268, Issue 9, Page(s) 3059–3071

    Abstract: ... Miller Fisher syndrome, acute myelitis, and posterior reversible encephalopathy syndrome (PRES) are also addressed ... Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is responsible ... case reports, case series, reviews, editorials, and other articles) was conducted and neurological sequelae ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in Wuhan, China in December 2019. It is evident that the COVID-19 pandemic has become a challenging world issue. Although most COVID-19 patients primarily develop respiratory symptoms, an increasing number of neurological symptoms and manifestations associated with COVID-19 have been observed. In this narrative review, we elaborate on proposed neurotropic mechanisms and various neurological symptoms, manifestations, and complications of COVID-19 reported in the present literature. For this purpose, a review of all current published literature (studies, case reports, case series, reviews, editorials, and other articles) was conducted and neurological sequelae of COVID-19 were summarized. Essential and common neurological symptoms including gustatory and olfactory dysfunctions, myalgia, headache, altered mental status, confusion, delirium, and dizziness are presented separately in sections. Moreover, neurological manifestations and complications that are of great concern such as stroke, cerebral (sinus) venous thrombosis, seizures, meningoencephalitis, Guillain-Barré syndrome, Miller Fisher syndrome, acute myelitis, and posterior reversible encephalopathy syndrome (PRES) are also addressed systematically. Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further clarify and assess the link between neurological complications and the clinical outcome of patients with COVID-19. To limit long-term consequences, it is crucial that healthcare professionals can early detect possible neurological symptoms and are well versed in the increasingly common neurological manifestations and complications of COVID-19.
    MeSH term(s) COVID-19 ; Headache ; Humans ; Nervous System Diseases/epidemiology ; Nervous System Diseases/etiology ; Pandemics ; Posterior Leukoencephalopathy Syndrome ; SARS-CoV-2
    Language English
    Publishing date 2021-01-23
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 187050-6
    ISSN 1432-1459 ; 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    ISSN (online) 1432-1459
    ISSN 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    DOI 10.1007/s00415-021-10406-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Síndrome de encefalopatía posterior reversible (PRES) asociado a SARS-CoV-2. Reporte de caso.

    Ordoñez-Boschetti, L / Torres-Romero, C M / Ortiz de Leo, M J

    Neurologia (Barcelona, Spain)

    2020  Volume 35, Issue 9, Page(s) 696–698

    Title translation Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report.
    Language Spanish
    Publishing date 2020-08-10
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1056021-x
    ISSN 1578-1968 ; 0213-4853
    ISSN (online) 1578-1968
    ISSN 0213-4853
    DOI 10.1016/j.nrl.2020.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top